Atrial natriuretic peptide protects against cisplatin-induced acute kidney injury

Reduction in the incidence of acute kidney injury after aortic arch surgery with low-dose atrial natriuretic peptide

(2014) Yosuke Mori et al.   EUROPEAN JOURNAL OF ANAESTHESIOLOGY

Atrial natriuretic peptide inhibits lipopolysaccharide-induced acute lung injury

(2014) Takashi Nojiri et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS

Results of Low-Dose Human Atrial Natriuretic Peptide Infusion in Nondialysis Patients With Chronic Kidney Disease Undergoing Coronary Artery Bypass Grafting

(2011) Akira Sezai et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Renal Protective Effects and the Prevention of Contrast-Induced Nephropathy by Atrial Natriuretic Peptide

(2009) Shuji Morikawa et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Natriuretic peptide/natriuretic peptide receptor-A (NPR-A) system has inhibitory effects in renal fibrosis in mice

(2009) Toshio Nishikimi et al.   REGULATORY PEPTIDES

Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care

(2008) Vincent Launay-Vacher et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies

(2008) N. Pabla et al.   KIDNEY INTERNATIONAL